Target intelligence / Profile preview

Sodium-glucose cotransporter protein subunit 2 (SGLT2)

Target
SGLT2
Molecular classification
Transporter, Membrane protein
01

Overview

The sodium-glucose cotransporter protein subunit 2 (SGLT2), encoded by the SLC5A2 gene, is a membrane protein primarily responsible for the reabsorption of glucose in the kidneys. Located on the apical membrane of epithelial cells lining the early segment (S1) of the proximal convoluted tubule, SGLT2 actively transports D-glucose with a sodium-to-glucose coupling ratio of 1:1. It reabsorbs approximately 80–90% of filtered glucose from glomerular filtrate back into circulation. SGLT2 is a therapeutic target for SGLT2 inhibitors (gliflozins), which are used to treat type 2 diabetes mellitus and provide cardiovascular and renal benefits.

Other names
SLC5A2Solute carrier family 5 member 2
02

Mechanism of action

Inhibition of renal tubular glucose reabsorption, leading to increased urinary glucose excretion and reduced blood sugar levels.

03

Biological functions

Renal glucose reabsorptionSodium-glucose symport
04

Disease associations

Type 2 diabetes mellitus
05

Safety considerations

Increased risk of urinary tract infectionsIncreased risk of genital infectionsDehydrationHypotensionDiabetic ketoacidosis (rare)Amputation (with canagliflozin)
06

Interacting drugs

Canagliflozin

3 more in the full profile.

Beyond the preview

Go deeper on Sodium-glucose cotransporter protein subunit 2 (SGLT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-glucose cotransporter protein subunit 2 (SGLT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call